Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.
about
Retinoid X Receptor Agonists Upregulate Genes Responsible for the Biosynthesis of All-Trans-Retinoic Acid in Human EpidermisPreclinical Evaluation of UAB30 in Pediatric Renal and Hepatic MalignanciesSteroid and Xenobiotic Receptor Signalling in Apoptosis and Autophagy of the Nervous System.Overexpression of microRNA-612 Restrains the Growth, Invasion, and Tumorigenesis of Melanoma Cells by Targeting Espin.
P2860
Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.
@ast
Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.
@en
type
label
Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.
@ast
Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.
@en
prefLabel
Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.
@ast
Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.
@en
P2093
P2860
P1476
Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.
@en
P2093
Alicia M Waters
Clinton J Grubbs
Donald D Muccio
Elizabeth A Beierle
Elizabeth Mroczek-Musulman
Jerry E Stewart
Venkatram R Atigadda
P2860
P304
P356
10.1158/1535-7163.MCT-14-1103
P577
2015-05-05T00:00:00Z